Web-based support for colorectal cancer patients and their caregivers
A Web-Based Dyadic Intervention to Manage Psychoneurological Symptoms for Patients With Colorectal Cancer and Their Caregivers
This study is testing a new online support program to help colorectal cancer patients and their caregivers manage symptoms like fatigue and depression during chemotherapy.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 56 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Emory University Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (Atlanta, Georgia) |
| Trial ID | NCT05663203 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates a web-based dyadic intervention designed to help manage psychoneurological symptoms in patients with colorectal cancer undergoing chemotherapy and their caregivers. The study involves developing a tailored intervention based on interviews with patient-caregiver dyads, followed by usability testing of the prototype. The feasibility and acceptability of the intervention will be assessed in a pilot trial with 20 dyads, measuring outcomes such as fatigue, depression, sleep disturbance, pain, cognitive dysfunction, and quality of life over an 8-week period.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older diagnosed with colorectal cancer, currently receiving chemotherapy, and experiencing at least two psychoneurological symptoms.
Not a fit: Patients with a Karnofsky Performance Scale score below 50 or caregivers with severe diseases may not benefit from this intervention.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the quality of life and symptom management for colorectal cancer patients and their caregivers.
How similar studies have performed: Other studies have shown promise in using web-based interventions for symptom management in cancer care, indicating potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
INCLUSION CRITERIA Patients: * Age \>= 18 years * Diagnosed with colorectal cancer * Life expectancy \> 12 months * Receiving active chemotherapy * Self-reported at least two psychoneurological symptoms (based on the symptom measures' cutoff scores) * Identified primary caregiver (i.e., family members or significant others identified by the patients as their primary source of emotional and physical support) * Access to the Internet * Fluent in English Caregivers: * Age \>= 18 years * Primary caregiver * Access to the Internet * Fluent in English EXCLUSION CRITERIA Patients: • Karnofsky Performance Scale \< 50 Caregivers: • Have severe diseases (e.g., cancer, heart disease)
Where this trial is running
Atlanta, Georgia
- Emory University/Winship Cancer Institute — Atlanta, Georgia, United States (Recruiting)
Study contacts
- Principal investigator: Yufen Lin, PhD, RN — Emory University Hospital/Winship Cancer Institute
- Study coordinator: Yufen Lin, PhD, RN
- Email: yufen.lin@emory.edu
- Phone: 404-712-9823
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.